PRE-PRINT COVID19 : Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 in vitro infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19 Authors:...
Bioaster vient de publier les génomes bactériens de son modèle de souris gnotobiotique (GM15), mis au point pour produire un nouveau modèle standardisé de souris avec un microbiote intestinal contrôlé...
BIOASTER first shareholder with its two co-founders Adama OUATTARA and Wassim ABOU-JAOUDE of Gencovery. Wishing success to the first BIOASTER start-up. Gencovery provides cutting-edge software based on digital organisms for...
Dr Nathalie Garçon, Directrice Générale et Scientifique de BIOASTER reçoit l’insigne d’Officier de la Légion d’honneur Nathalie Garçon, PharmD, PhD, Directrice Générale et Directrice scientifique de l’Institut de Recherche Technologique BIOASTER...
This #Multiomics study, combining #Metabolomics and #Transcriptomics, aims at deciphering the pathways involved in the immune response induced by an immune-stimulant in chickens. This work is part of a collaboration...
“Caecal microbiota compositions from 7-day-old chicks reared in high-performance and low-performance industrial farms and systematic culturomics to select strains with anti-Campylobacter activity”. Voir l’article. Ce travail mené en collaboration avec...
Nous avons développé une technologie microfluidique#microfluidics en gouttelettes pour mesurer la cinétique de la sécrétion de protéines #proteinsecretion à partir de cellules uniques #singlecells. Cette technologie a été utilisée avec...
BIOASTER se félicite du réengagement fort et clair de l’Etat auprès des IRT pour développer et dynamiser la recherche technologique française. Cet accompagnement va donner à l’Institut de Recherche Technologique...
Venez voir notre nouvelle vidéo en ligne sur les EXPERTISES @BIOASTER à propos des SMART OMICS: Vidéo SMART OMICS L’équipe du pôle OMICS de BIOASTER vous présente le concept de...
BIOASTER a conclu un accord de collaboration avec Takeda pour développer et valider de nouvelles approches basées sur le microbiome dans le contexte des actifs de Takeda au stade clinique...
Through this collaboration, BIOASTER and MaaT Pharma illustrate once again the dynamism and quality of the French ecosystem in the promising field of microbiome, as well as the success of...
By continuing browsing this website, you accept the use of cookies or other tracers for statistics of visits to optimize the functionality of the site, and or privacy policy. AcceptRejectRead More
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
